<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Initial Completeness Assessments for Type II Active Pharmaceutical Ingredient Drug Master Files Under the Generic Drug User Fee Amendments of 2012</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Initial Completeness Assessments for Type II Active Pharmaceutical Ingredient Drug Master Files Under the Generic Drug User Fee Amendments of 2012</h1>
    <p class="timestamp">Published: 2012-10-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is announcing the availability of a draft guidance for industry entitled "Initial Completeness Assessments for Type II API DMFs Under GDUFA." Under the Generic Drug User Fee Amendments of 2012 (GDUFA), holders of certain drug master files, namely, Type II active pharmaceutical ingredient (API) drug master files (DMFs) that are referenced in generic drug applications, or in amendments or prior approval supplements to these applications, will be...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-24325</p>
    <p><strong>Publication Date:</strong> 2012-10-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/10/02/2012-24325/draft-guidance-for-industry-on-initial-completeness-assessments-for-type-ii-active-pharmaceutical">https://www.federalregister.gov/documents/2012/10/02/2012-24325/draft-guidance-for-industry-on-initial-completeness-assessments-for-type-ii-active-pharmaceutical</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-24325</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
